BrightGene Bio-Medical Technology Company Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 745
Employees
  • Stock Symbol
  • 688166
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $4.51
  • (As of Friday Closing)

BrightGene Bio-Medical Technology Company General Information

Description

Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Primary Office
  • Building C25-28
  • No. 218 Xinghu Road, SIP
  • Suzhou, Jiangsu 215011
  • China
+86 0512 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BrightGene Bio-Medical Technology Company Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.51 $4.78 $4.45 - $9.53 $1.85B 410M 1.81M $0.07

BrightGene Bio-Medical Technology Company Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,654,713 2,828,231 1,839,130
Revenue 144,976 113,682 72,820 61,600
EBITDA 38,704 30,991 20,951 14,724
Net Income 30,622 24,590 16,077 11,066
Total Assets 348,940 279,765 203,135 127,246
Total Debt 84,253 33,688 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BrightGene Bio-Medical Technology Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BrightGene Bio-Medical Technology Company‘s full profile, request access.

Request a free trial

BrightGene Bio-Medical Technology Company Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of
Biotechnology
Suzhou, China
745 As of 2020
00000
0000 0000-00-00
00000000 00000

000000 0

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
000000000000000
Plankstadt, Germany
0000 As of 0000
00000 00000

0000 000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
0000 000000000
Ness Ziona, Israel
00 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BrightGene Bio-Medical Technology Company Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corden Pharma Venture Capital-Backed Plankstadt, Germany 0000 00000 00000
0000 000000 Venture Capital-Backed Ness Ziona, Israel 00 00000 0000000000 00000
0000000 Private Equity-Backed East Rutherford, NJ 0000 000000000000
000000 00000000000 Private Equity-Backed South San Francisco, CA 00 00000 0000000 0000 00000
0000000 Private Equity-Backed Dreieich, Germany 0000 000000&0
You’re viewing 5 of 14 competitors. Get the full list »

BrightGene Bio-Medical Technology Company Executive Team (3)

Name Title Board Seat Contact Info
Yuan Zou Chief Financial Officer
Jiandong Yuan Chairman, Founder & General Manager
Richard Chan Marketing Director
To view BrightGene Bio-Medical Technology Company’s complete executive team members history, request access »

BrightGene Bio-Medical Technology Company Board Members (2)

Name Representing Role Since
Jiandong Yuan BrightGene Bio-Medical Technology Company Chairman, Founder & General Manager 000 0000
Yi Shi Ph.D Lilly Asia Ventures Board Member 000 0000
To view BrightGene Bio-Medical Technology Company’s complete board members history, request access »

BrightGene Bio-Medical Technology Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrightGene Bio-Medical Technology Company Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000 31-Aug-2021 00000 00000 00 000.00 Drug Discovery
00000 0000 000 18-Dec-2020 00000 00000 00 Biotechnology
00000000000 000000 19-Nov-2020 00000 00000 00 Biotechnology
0000000 02-Jul-2020 00000 00000 00 000.00 Drug Discovery
Citryll 03-Jul-2019 Early Stage VC 0000 Drug Discovery
You’re viewing 5 of 6 investments. Get the full list »